Odyssea Pharma is a pharmaceutical production site based in Liège, Belgium, part of the Allergan plc group.
Our success is based on the commitment of our teams on the site and around the world.
Odyssea Pharma sprl is one of the Allergan Group's centers of excellence for women's health, offering the GMP manufacturing of the Levosert ™ hormonal intrauterine device and a quality and regulatory expertise from a dedicated site located in Liège (Grace-Hollogne), in Belgium.
The company has successfully developed the Levosert ™ (levonorgestrel-releasing intrauterine device) and today launches the mass production of the hormonal IUD with almost unique equipment for the global market.
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold global pharmaceutical company, leader in a new industrial model, Growth Pharma. Allergan, with a commercial presence in nearly 100 countries, works with physicians, healthcare providers and patients to deliver innovative and useful treatments, helping people around the world live longer and better.
Our company owes much of its success to the commitment of its 16,000 employees, who, all over the world, work boldly for the health of as many people as possible (Bold for Life). Together, we build relationships, build strength, act quickly, and achieve results for our clients and patients around the world, always doing what is right.
Allergan is a leader in Open Science *. This model, adopted by the company in research and development, defines our approach to research and grow ideas and innovations that change the game to provide better patient care. This approach has allowed Allergan to create one of the largest pipeline of products under development in the pharmaceutical sector, with over 70 programs in the middle and advanced stages of development.
Allergan offers a portfolio of high value-added products in the following therapeutic areas: neurology, ophthalmology, medical aesthetics, gastroenterology, gynecology / obstetrics, urology, cardiovascular diseases and infection prevention.